CEP-28122
CEP-28122 is a potent, selective, and orally bioavailable small molecule inhibitor of anaplastic lymphoma kinase (ALK) . It is utilized in preclinical research to investigate ALK-driven pathologies, demonstrating efficacy in both cellular assays and animal models of ALK-positive cancers.
Product Specifications
CAS Number
1022958-60-6
Product Name Alternative
CEP28122, CEP-28122, CEP 28122, Cluster of differentiation 246, CD246, Anaplastic lymphoma kinase, Anaplastic lymphoma kinase (ALK), ALK, ALK tyrosine kinase receptor, Inhibitor, inhibit
Field of Research
Cardiovascular Research, Signal Transduction
Purity
99.87% (May vary between batches)
Solubility
DMSO:10 mM
Smiles
N ([C@@H]1[C@@]2 (C[C@] ([C@@H]1C (N) =O) (C=C2) [H]) [H]) C3=NC (NC=4C (OC) =C5C (=CC4) CC[C@@H] (CC5) N6CCOCC6) =NC=C3Cl
Molecular Formula
C28H35ClN6O3
Molecular Weight
539.07
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog